SCHEMBL30590664

SCHEMBL30590664

O=C(O)C(=O)c1[nH]cc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.42
ALDH1A1 P00352 5/20 0.41
HTT P42858 2/20 0.41
HPGD P15428 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HNF4A P41235 1/20 0.37
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAP2 P11137 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PRKAB2 O43741 1/20 0.36
PRKAG1 P54619 1/20 0.36
PRKAA2 P54646 1/20 0.36
PRKAA1 Q13131 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28080968 0.79 ALDH1A1 (0.41) PARP1ALDH1A1HTTHPGDKDM4E
SCHEMBL26112712 0.79 ALDH1A1 (0.48) ALDH1A1HTTHPGDKDM4EALOX15
SCHEMBL3494606 0.71 MAPT (0.43) ALDH1A1HTTHPGDKDM4EHSD17B10
SCHEMBL4792528 0.69 PARP1 (0.45) PARP1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL29750764 0.68 CCNC (0.51) PARP1ALDH1A1HTTHPGDALOX15
SCHEMBL12912923 0.67 PARP1 (0.44) PARP1ALDH1A1HTTHPGDHSD17B10
Hydrochloric Acid SCHEMBL28338871 0.67 CHEK1 (0.44) PARP1ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL29264066 0.67 LMNA (0.44) PARP1ALDH1A1HTTHPGDKDM4E
SCHEMBL9459084 0.67 HTT (0.50) PARP1ALDH1A1HTTALOX15KMT2A
SCHEMBL5534778 0.67 ALDH1A1 (0.47) PARP1ALDH1A1HTTHPGDHNF4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4504341-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE Shy Therapeutics LLC (US) 2025-02-12 EP disclosed
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed